🇺🇸 FDA
Patent

US 8980838

Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction

granted A61KA61K38/12A61K45/00

Quick answer

US patent 8980838 (Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/12, A61K45/00, A61K45/06, A61P